Vortex Web Site
of the Dialysis World
B. Braun -
Updated Analysis of Pivotal Study Reveals: Proactive, High Dosage of Venofer® Significantly Reduces Risk of Death or Major Cardiovascular Events in Haemodialysis Patients
(3-page pdf) Press release (Business Wire version) from Vifor Pharma Group. Vifor Fresenius Medical Care Renal Pharma Ltd. is a joint company of Vifor Pharma Group and Fresenius Medical Care.
Read Legal Disclaimer
Copyright© 2019 RenalWEB. All
where noted, no material within the RenalWEB web sites can be copied,
duplicated, or reproduced in any form without written consent from RenalWEB.